Chalazion & Hordeolum

Overview

Chalazion and hordeolum are both common inflammatory eyelid lesions arising from the glands of the eyelid margin, but they differ fundamentally in mechanism, acuity, and typical management. A chalazion is a chronic, sterile, granulomatous inflammatory reaction to retained, obstructed secretion from a meibomian gland (or, less commonly, a gland of Zeis), while a hordeolum ("stye") is an acute, typically infectious (usually staphylococcal) inflammation of an eyelid gland, presenting as a painful, erythematous, tender nodule.¹

Epidemiology & Risk Factors

Chalazion and hordeolum are together among the most frequently encountered eyelid conditions across the age spectrum. In an 8-year review of a military teleophthalmology program, hordeolum/chalazion was the single most common diagnosis among ophthalmology consultations, accounting for 39.3% of cases — more common even than viral conjunctivitis (20.3%) — illustrating just how prevalent these conditions are in general and remote-access eye care settings.² Risk factors for both conditions include chronic blepharitis and meibomian gland dysfunction, which predispose to gland obstruction and secondary inflammation or infection.

Pathophysiology

A chalazion develops when a meibomian (or Zeis) gland duct becomes obstructed, causing retained lipid-rich secretion to leak into the surrounding tarsal tissue and provoke a granulomatous, lipogranulomatous inflammatory response — a process that is non-infectious in nature, distinguishing it fundamentally from hordeolum. A hordeolum, by contrast, is an acute suppurative infection, most commonly staphylococcal, of a meibomian gland (internal hordeolum) or a gland of Zeis/Moll at the lash line (external hordeolum), producing the classic acute, painful inflammatory presentation.

Clinical Presentation

Chalazion typically presents as a slowly enlarging, painless (or minimally tender), firm nodule within the tarsal plate, often noticed incidentally or because of its cosmetic appearance or, if large, mechanical effects on the globe (induced astigmatism, mild ptosis). Hordeolum presents acutely with pain, redness, swelling, and tenderness localized to the affected gland, sometimes with a visible pustule at the lash line (external hordeolum) or pointing toward the conjunctival surface (internal hordeolum).

Exam Findings

• Chalazion: a firm, mobile, typically painless nodule within the tarsal plate, sometimes visible or palpable through the conjunctival surface on lid eversion
• Hordeolum: an acutely inflamed, tender, erythematous swelling, often with a visible point of purulent discharge
• Associated blepharitis or meibomian gland dysfunction findings (lid margin telangiectasia, gland orifice plugging, altered meibum quality) are common in both conditions
• Chronic or recurrent lesions, or those with an atypical, non-resolving, or ulcerated appearance, should raise concern for an eyelid malignancy masquerading as a chalazion, particularly in older patients

Differential Diagnosis

• Sebaceous gland carcinoma masquerading as a recurrent or atypical chalazion — a critical differential in any older patient with a chalazion that recurs after treatment or fails to resolve as expected
• Preseptal or orbital cellulitis (more diffuse periorbital erythema and swelling, often with systemic signs, distinguishing it from a localized hordeolum)
• Dermoid cyst or other congenital eyelid/orbital lesion in a child (typically present from early life, distinct location and consistency)
• Insect bite reaction or other localized allergic/inflammatory eyelid swelling

Management

Most chalazia and hordeola are managed conservatively, and there remains no single universally agreed treatment of choice given the range of effective options available.¹ First-line conservative measures include warm compresses, lid hygiene, and topical antibiotic ointment with or without a topical corticosteroid component, particularly for hordeolum or early/small chalazion.¹ For chalazia that persist despite conservative measures, intralesional corticosteroid injection (typically triamcinolone acetonide) is a well-established, effective option, and surgical incision and curettage is reserved for lesions that fail both conservative treatment and steroid injection, or for larger, more established lesions.¹

Additional, less mainstream approaches described in the literature include botulinum toxin A injection, tarsal trephination, and laser or cryotherapy-based removal, reflecting the ongoing search for optimal, minimally invasive management, though none of these has yet displaced the standard conservative-to-stepwise-invasive treatment ladder.¹ A small pilot study exploring oral probiotic supplementation alongside conservative treatment for adult small chalazia found a significantly shorter time to complete resolution in the probiotics group compared with conservative treatment alone, hypothesized to reflect a "gut-eye axis," though medium and large chalazia did not respond to either conservative approach within the study's follow-up period — an intriguing but preliminary finding requiring further, larger studies before it can inform routine practice.³

Complications

• Chalazion recurrence after treatment, particularly with incomplete removal during incision and curettage
• Induced astigmatism or mild mechanical ptosis from a large, longstanding chalazion exerting pressure on the globe or eyelid
• Preseptal cellulitis as a rare complication of an untreated or secondarily infected hordeolum or chalazion
• Missed eyelid malignancy in a lesion recurrently or persistently misdiagnosed as a simple chalazion, particularly in older patients
• Scarring or cosmetic sequelae from surgical incision and curettage, though generally minimal with proper technique

Clinical Pearls

• Chalazion is a chronic, sterile, granulomatous process from gland obstruction, while hordeolum is an acute, typically infectious process — a distinction guiding urgency and choice of initial treatment
• Hordeolum/chalazion is an extremely common presenting complaint, accounting for the largest share of ophthalmology consultations in some large teleophthalmology cohorts²
• A stepwise approach — conservative measures, then intralesional steroid, then incision and curettage for refractory lesions — remains the standard, evidence-based treatment ladder, since no single universal treatment of choice has been established¹
• Any recurrent, atypical, or non-resolving "chalazion" in an older patient warrants biopsy to exclude sebaceous gland carcinoma
• Emerging adjuncts (oral probiotics, botulinum toxin, tarsal trephination) remain investigational and should not replace the established conservative-to-surgical treatment ladder¹³

Common Pitfalls

• Assuming every eyelid nodule is a benign chalazion without considering malignancy in an atypical or recurrent presentation
• Proceeding directly to surgical incision and curettage without first attempting conservative measures and, where appropriate, intralesional steroid injection
• Confusing hordeolum with preseptal or orbital cellulitis, or failing to recognize when diffuse periorbital signs suggest a more serious infection requiring different management
• Overemphasizing preliminary findings (such as the small probiotics pilot study) as established treatment recommendations rather than hypothesis-generating preliminary data
• Neglecting to address underlying blepharitis or meibomian gland dysfunction, a common contributor to recurrence of both conditions